The Journal of Urology® Home Study Course 2013 Volume 189/190

AUA CME Requirements

Program Description and Objectives: The Journal of Urology® Home StudyCourse is a comprehensive learning activity developed by a team of educa-tors, academicians and clinicians. After completing each lesson, the partici-pants should be able to assess their knowledge of urology, demonstrate anincreased knowledge base of urology, and apply the increased knowledge toimprove quality of patient care.

Accreditation: The American Urological Association (AUA) is accredited by theAccreditation Council for Continuing Medical Education (ACCME) to provide con-tinuing medical education for physicians.

Credit Designation: The American Urological Association (AUA) designatesthis enduring material for a maximum of 24.0 AMA PRA Category 1 Cred-its™. Physicians should claim only the credit commensurate with the extentof their participation in the activity.

Target Audience: The Journal of Urology® Home Study Course is designedfor practicing urologic physicians, American Board of Urology (ABU) candi-dates and/or residents.

Method of physician participation in the learning process: Two volumes ofThe Journal of Urology® are published annually. Each volume is comprisedof 6 issues. Five clinically relevant articles are selected by the editor to beoffered for CME in each issue of The Journal. For CME credit, the partici-pant must be enrolled in the home study course for the year, complete thequestionnaire on the opposite page and submit answers online at www.AUAnet.org/cmetests, answering 80% of the test questions correctly.Please complete the accompanying evaluation. Each issue is designated for amaximum of 2.0 AMA PRA Category 1 Credits™.

Estimated time to complete each lesson: 2.0 hours.

Program Enrollment: The cost to enroll in The Journal of Urology® HomeStudy Course 2013 Volumes 189/190 is only $60 for the full year. There are3 convenient ways to enroll:

● by MAIL: send completed form below including check or credit card infor-mation to address given below

●by FAX: send completed form below with credit card information to 410-689-3912

●ONLINE at www.AUAnet.org/JUHomeStudy2013

Fax: 1-410-689-3912

0022-5347/13/1901-0368/0THE JOURNAL OF UROLOGY®

© 2013 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.

368 www.jurology.com

This product is only available to subscribers of The Journal of Urology®.Upon receipt of payment, you will have access to the online posttests atwww.AUAnet.org/cmetests. Online exams are also available for 2011 (vol.185/186) and 2012 (vol. 187/188).

AUA Disclosure Policy: All persons in a position to control the content of aneducational activity (i.e., activity planners, presenters, authors) participating inan educational activity provided by the AUA are required to disclose to theprovider any relevant financial relationships with any commercial interest. TheAUA must determine if an individual’s relationships may influence the educa-tional content and resolve any conflicts of interest prior to the commencement ofthe educational activity. The intent of this disclosure is not to prevent individ-uals with relevant financial relationships from participating but rather to pro-vide learners the information with which they can make their own judgments.

Evidence Based Content: It is the policy of the AUA to ensure that thecontent contained in this CME activity is valid, fair, balanced, scientificallyrigorous, and free of commercial bias.

Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUAto require the disclosure of all references to off-label or unapproved uses of drugsor devices prior to the presentation of educational content. The audience isadvised that this continuing medical education activity may contain reference(s)to off-label or unapproved uses of drugs or devices. Please consult the productprescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, au-thors, and other experts whose input is included in this program are theirown and do not necessarily represent the viewpoint of the AUA.

System Requirements for Online Test: A PC-compatible computer runningWindows XP, or a Macintosh computer running OS X 10.1 or later. Internetaccess. Adobe Acrobat Reader 9 or newer.

Release Date: issue month, 2013. Expiration Date: issue month, 2016.

Copyright © 2013 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND

RESEARCH, INC.

AUA Privacy and Confidentiality Policy:

http://www.AUAnet.org/cme/onlineeduconf.cfm

Email cme@AUAnet.org or hstudy@AUAnet.org with any questions.

The Journal of Urology® Home Study Course Enrollment Form

e Yes! I’d like to enroll for 2013 Volumes 189/190 for only $60! AUA ID:

Name:

Address:

City: State: Zip/Postal Code:

e ONLINE: www.AUAnet.org/JUHomeStudy2013

e Check (in US dollars drawn on a U.S. bank) enclosed for $ payable to: AUA Education and Research, Inc.

e Credit Card payment: e Visa e MasterCard e AmEx e Discover

Card Number: Expiration (mm/yyyy):

Cardholder’s Name (please print): Cardholder’s Signature:

Please mail or fax enrollment form to: American Urological AssociationP.O. Box 791080Baltimore, MD 21279-1080Telephone: 1-866-746-4282, ext. 3747

http://dx.doi.org/10.1016/j.juro.2013.04.050Vol. 190, 368-369, July 2013

Printed in U.S.A.

369

CME QUESTIONS FOR JULY 2013 ISSUE OF THE JOURNAL OF UROLOGY®

1. PATHOLOGICAL, ONCOLOGIC AND FUNCTIONAL OUTCOMES OF RADICAL PROSTATECTOMY FOLLOW-ING ACTIVE SURVEILLANCE (vol. 190, pp. 91�96)

Compared to patients with prostate cancer eligible for active surveillance who underwent immediate radicalprostatectomy, those who underwent radical prostatectomy after a period of active surveillance were:

a) more likely to have extracapsular extensionb) more likely to have nodal involvementc) more likely to have biochemical recurrenced) more likely to have erectile dysfunctione) more likely to have incontinence

2. LONG-TERM EFFECTS OF DOXAZOSIN, FINASTERIDE AND COMBINATION THERAPY ON QUALITY OFLIFE IN MEN WITH BENIGN PROSTATIC HYPERPLASIA (vol. 190, pp. 187�193)

According to the current available evidence, which of the following drugs for benign prostatic hyperplasia is/areassociated with long-term beneficial effects on general patient reported quality of life as measured by the MedicalOutcomes Study Short Form-36?

a) doxazosin aloneb) finasteride alonec) doxazosin combined with finasterided) all of the abovee) none of the above

3. TRIFECTA NERVE COMPLEX: POTENTIAL ANATOMICAL BASIS FOR MICROSURGICAL DENERVATIONOF THE SPERMATIC CORD FOR CHRONIC ORCHIALGIA (vol. 190, pp. 265�270)

The 3 primary areas in the spermatic cord in men with chronic orchialgia (or scrotal content pain) that displayedevidence of wallerian degeneration in the nerves are:

a) perivasal sheath, anterior perivenous tissue and medial pericord lipomab) central periarterial tissue, lateral perivascular tissue and medial perivascular tissuec) peritesticular artery tissue, medial perivenous tissue and lateral perivenous tissued) cremasteric muscle fibers, perivasal sheath and posterior cord lipomatous tissuese) cremasteric muscle fibers, medial perivascular tissue and anterior perivenous tissue

4. THE IMPACT OF PROSTATE VOLUME, NUMBER OF BIOPSY CORES AND AUA SYMPTOM SCORE ON THESENSITIVITY OF CANCER DETECTION USING THE PROSTATE CANCER PREVENTION TRIAL RISK CAL-CULATOR (vol. 190, pp. 70�76)

Which factor lowers the chance of detection of prostate cancer on biopsy?

a) larger prostate volumeb) older agec) lower AUA total symptom scored) African-American racee) no history of a prior negative biopsy

5. COMPARATIVE PERFORMANCE OF COMORBIDITY INDICES FOR ESTIMATING PERIOPERATIVE AND5-YEAR ALL CAUSE MORTALITY FOLLOWING RADICAL CYSTECTOMY FOR BLADDER CANCER (vol. 190,pp. 55�60)

Which of the following clinicopathological variables is associated with a significantly increased risk of patients’ deathfrom any cause within 90 days of radical cystectomy?

a) older patient age at surgeryb) male genderc) higher American Society of Anesthesiologists scored) lymph node positive statuse) receipt of perioperative chemotherapy

Publication date: July 2013

Expiration date: July 2016